✦ LIBER ✦

A novel immunoregulatory regimen combining high dose interleukin-2 and taurolidine for the treatment of patients with progressive metastatic melanoma

✍ Scribed by G. C. O’Brien; R. A. Cahill; M. J. O’Sullivan; D. J. Bouchier-Hayes; H. P. Redmond

Book ID: 105723822
Publisher: Springer-Verlag
Year: 2002
Tongue: English
Weight: 242 KB
Volume: 171
Category: Article
ISSN: 1863-4362
DOI: 10.1007/bf03170354

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Should High-Dose Interleukin-2 Still Be

Should High-Dose Interleukin-2 Still Be the Preferred Treatment for Patients with Metastatic Melanoma?

✍ Dillman, Robert O.; Barth, Neil M.; VanderMolen, Louis A.; Mahdavi, Khosrow; McC 📂 Article 📅 2012 🏛 Mary Ann Liebert 🌐 English ⚖ 263 KB

Comparison of acute toxicity and mortali

Comparison of acute toxicity and mortality after two different dosing regimens of high-dose interleukin-2 for patients with metastatic melanoma

✍ Laura M. Alwan, Kenneth Grossmann, Daniel Sageser, Joan Van Atta… 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 252 KB

Phase II trial of recombinant human inte

Phase II trial of recombinant human interleukin-2 and interferon-alpha-2a: Implications for the treatment of patients with metastatic melanoma

✍ Omar Eton; Moshe Talpaz; Kyoo H. Lee; Jeanne M. Rothberg; Joanna M. Brell; Rober 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 664 KB

Phase II trial of a novel capecitabine d

Phase II trial of a novel capecitabine dosing schedule in combination with lapatinib for the treatment of patients with HER2-positive metastatic breast cancer

✍ Devika Gajria; Joseph Gonzalez; Kimberly Feigin; Sujata Patil; Carol Chen; Maria 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 219 KB

Chemoimmunotherapy with dacarbazine, cis

Chemoimmunotherapy with dacarbazine, cisplatin, interferon-alpha2b and interleukin-2 versus two cycles of dacarbazine followed by chemoimmunotherapy in patients with metastatic melanoma: A randomised phase II study of the European Organization for Research and Treatment of Cancer Melanoma Group

✍ C.J.A. Punt; S. Suciu; M.A. Gore; J. Koller; W.H.J. Kruit; J. Thomas; P. Patel; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 150 KB

High-dose interleukin-2 for the treatmen

High-dose interleukin-2 for the treatment of metastatic renal cell carcinoma : A retrospective analysis of response and survival in patients treated in the surgery branch at the National Cancer Institute between 1986 and 2006

✍ Jacob A. Klapper; Stephanie G. Downey; Franz O. Smith; James C. Yang; Marybeth S 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB 👁 1 views